Z Peelay, S Saha, V Patil, N Menon, A Singh, M Shah, A Sahu, A Ubharay, O R Chowdhury, K Prabhash, V Noronha
AIMS: Sinonasal teratocarcinosarcomas (SNTCS) are rare sinonasal malignancies, the incidence of which is less than 1% of all tumors. There is limited data available on SNTCS's, often as case reports and small case series. The management of SNTCS is complicated because of its location, locally aggressive biology, difficulty in achieving complete resection, and limited data on chemotherapy in these malignancies. This audit was performed to understand the role of neoadjuvant chemotherapy (NACT) in SNTCS's, its ability to downstage the disease, achieve complete resection, and impact on long-term survival outcomes...
March 19, 2024: Clinical Oncology: a Journal of the Royal College of Radiologists